Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty

January 20, 2025 updated by: LifeBridge Health

Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot

Patients with degenerative joint disease can effectively be treated with a primary total knee replacement to reduce pain and improve function in their daily lives. Theoretically, achievement of normal knee motion using a medial pivot design in total knee replacements can be recreated in comparison to single radius designs, which could lead to an improvement in post-surgical outcomes and satisfaction with the procedure. The aim of this study is to compare two types of implant designs (medial pivot and single radius) in a total knee replacement using clinical outcomes, patient reported outcomes, and overall function assessed by a specialized gait laboratory.

Study Overview

Detailed Description

This is a single center, cohort study in 100 adult subjects undergoing primary total knee arthroplasty that will receive one of the two total knee device systems.

Primary total knee replacement is an effective treatment for relieving pain and improving function for patients with degenerative joint disease. Recently, design of knee implants in a total knee replacement have received increased interest, particularly the medial pivot designs. Single-radius implants are designed to minimize instability throughout the functional range of movement. Medial pivot total knee designs theoretically recreate more normal knee motion when compared to single radius designs. Both implant designs are commonly used for total knee replacements. Outcomes of TKA are evaluated by multiple methods including implant/device survivorship, radiographic assessments, clinical examinations, and patient reported outcome measures (PROMS). Laboratory based gait analysis performed at a specialized research facility is not commonly conducted in patients with positive outcomes post-surgery as this is associated with high cost. There is currently not enough research comparing these two designs directly. Research is required to determine which design may provide better clinical outcomes and satisfaction with the procedure.

In addition to your normal standard clinical care, there will be scheduled pre-operative, operative, 6-week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visits.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Subject is male or non-pregnant female aged between 18 and 75 years of age.
  • Subject is willing to provide informed consent to participate in the research study.
  • Subject is indicated for a primary total knee arthroplasty (TKA) based on the approved labeling of knee implant, either a medial pivot or single radius design, specifically: MicroPort Evolution Medial-Pivot Knee System, Cruciate Retaining (CS) or Stryker Triathlon Tritanium (CS)
  • Subject does not have a history of previous prosthetic replacement device on the operative knee.
  • Subject is currently ambulating and does not have a condition on the contralateral limb in the opinion of the investigator that would interfere with the gait laboratory evaluations.
  • Subject is willing and able to comply with the schedule of events for the study and is available to return to the clinic for all required follow-up visits.

Exclusion Criteria:

  • Subject has a Body Mass Index (BMI) >40
  • Subject has a diagnosis of avascular necrosis or inflammatory arthritis.
  • Subject has any mental or neuromuscular disorder that would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care.
  • Subject is a prisoner
  • Subject has any condition, in the opinion of the Investigator that might interfere with the evaluation of the study objectives.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Medial-Pivot Knee System
Total Knee Arthroplasty will be done by implanting the MicroPort Medial Pivot Knee System into subjects.
Medial Pivot Knee System
Active Comparator: Single Radius Design Total Knee System
Total Knee Arthroplasty will be done by implanting the Stryker Triathlon Tritanium Knee System into subjects.
Single Radius Design Total Knee System

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Knee Mechanics
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Knee flexion/extension, varus/valgus, and internal/external rotation will be measured (in degrees) and analyzed using the KneeKG system during incline and decline walking.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Anterior/Posterior Knee Translation
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
This parameter will be measured (in mm) and analyzed using the KneeKG system during incline and decline walking.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Initial Peak Loading Force
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
This parameter will be measured (in N) and analyzed using the KneeKG system during normal walking.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Active and Passive Range of Motion
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Active and passive range of motion will be measured (in degrees) using a goniometer.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Quadriceps Lag
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Quadriceps lag will be measured (in degrees) in both the sitting and supine positions.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Timed up and Go Test (TUG)
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
This parameter will be measured in seconds and requires a patient to rise from a chair walk three meters and return to the chair again as quickly as possible.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Five Times Sit to Stand Test
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
This parameter will be measured in seconds and will collect the amount of time it takes a patient to transfer from a seated to a standing position and back to sitting five times.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Single Limb Stance Test for Both Knees
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
This parameter will be measured in seconds and will collect the amount of time a patient is able to stand unassisted on one leg.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Timed Ascent and Descent of One Flight of Stairs Test
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
This parameter will be measured in seconds and will collect the amount of time it takes a patient to ascend and descend one flight of stairs (8-14 steps).
Pre-operative; Post-operative - 3 month and 12 month follow-up visit
Change in Quadriceps Muscle Strength
Time Frame: Pre-operative; Post-operative - 3 month and 12 month follow-up visit
This parameter will be measured (in lbs/in) using a dynamometer for quadricep muscle strength assessment.
Pre-operative; Post-operative - 3 month and 12 month follow-up visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant Survivorship
Time Frame: Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
Radiographic assessment using AP and lateral knee X-rays to analyze implant position, radiolucencies, fracture, and osteolysis.
Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
Post-surgical Complications
Time Frame: Operative visit; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
All complications related to the procedure will be documented.
Operative visit; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
Evidence of Osteolysis
Time Frame: Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
X-rays will be evaluated to look for presence of a radiolucent area, especially > 2mm, around implant or cement with sclerotic border.
Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
Change in Knee Society Score (KSS) Short Form
Time Frame: Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
25 question items assessing symptoms, patient satisfaction, patient expectation, and their level of functional activity of their knee. Scores range from 0-100 with higher scores representing better outcomes.
Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
42 question items assessing a patient's opinion about their health, symptoms, and function of their knee. Scores range from 0-100 with zero representing severe knee problems and 100 indicating no knee problems.
Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
Change in Patient Reported Outcomes Measurement Information System (PROMIS-10)
Time Frame: Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
10 question items assessing overall physical, mental, and social health of the patient. Each question item is scored separately on 1-5 scale and total scores are combined into 2 groups - Global Physical Health Score and Global Mental Health score. A T-score is calculated with the 2 previous scores against the general population with a higher T-score representing better outcomes.
Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
Change in Forgotten Joint Score FJS
Time Frame: Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit
12 question items evaluating how "aware" a patient is of their operative joint during daily activities. Scores range between 0-100 with higher scores indicating a patient is able to forget the joint on a daily basis or low joint awareness.
Pre-operative; Post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James Nace, MD, LifeBridge Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Estimated)

July 1, 2030

Study Completion (Estimated)

July 1, 2030

Study Registration Dates

First Submitted

February 3, 2021

First Submitted That Met QC Criteria

March 22, 2021

First Posted (Actual)

March 24, 2021

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 20, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on MicroPort Evolution Medial-Pivot Knee System (Cruciate-substituting)

Subscribe